Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule

Rhea-AI Summary

Maravai LifeSciences (NASDAQ: MRVI) is set to participate in several upcoming investor conferences. CFO Kevin Herde will engage in a fireside chat at the UBS Global Healthcare Conference on May 25, 2022, followed by a presentation at the William Blair Growth Conference on June 8, 2022. Additionally, Mr. Herde will participate in another fireside chat at the Goldman Sachs Global Healthcare Conference on June 14, 2022. Webcasts of these events will be available on the Maravai Investor Relations website, along with archived versions post-event.

Positive

• Participation in multiple investor conferences enhances visibility and investor engagement.
• Scheduled presentations by CFO potentially indicate strong corporate communication strategies.

Negative

• None.

SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of May and June.

On May 25^th, 2022, at 7:45 a.m. PT, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the UBS Global Healthcare Conference being held in New York City, New York.  

On June 8^th, 2022, at 8:40 a.m. PT, Mr. Herde will present at the William Blair Growth Conference being held in Chicago, Illinois.

On June 14^th, 2022, at 2:40 p.m. PT, Mr. Herde will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference being held in Rancho Palos Verdes, California.

A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under Events and Presentations. An archived version of the webcasts will also be available on the Maravai website following the completion of each event.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. For more information about Maravai LifeSciences, visit www.maravai.com.

FAQ

What are the upcoming investor conferences for MRVI in 2022?

Maravai LifeSciences is participating in the UBS Global Healthcare Conference on May 25, the William Blair Growth Conference on June 8, and the Goldman Sachs Global Healthcare Conference on June 14.

Who will represent Maravai LifeSciences at the investor conferences?

CFO Kevin Herde will represent Maravai LifeSciences at all scheduled investor conferences.

Where can I watch the presentations for Maravai LifeSciences?

Live webcasts of Maravai's presentations will be available on their Investor Relations website, along with archived versions after each event.

What is the significance of Maravai LifeSciences' participation in investor conferences?

Participation in investor conferences can enhance company visibility, foster investor relations, and potentially attract new investors.